Huw M. Nash Stoke Therapeutics, Inc. (STOK) insider trading activity

Huw M. Nash is Chief Business Officer of Stoke Therapeutics, Inc.. Currently has a direct ownership of 0 shares of STOK, which is worth approximately $0. The most recent transaction as insider was on Jan 06, 2021, when has been sold 32 shares (Common Stock) at a price of $57.14 per share, resulting in proceeds of $1,828. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Huw M. Nash Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2021	SELL Open market or private sale	$1,828 $57.14 p/Share	32 Reduced 100.0%	0 Common Stock
Jan 04 2021	SELL Open market or private sale	$337,782 $59.26 p/Share	5,700 Reduced 99.44%	32 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 49.86%	5,732 Common Stock
Dec 18 2020	SELL Open market or private sale	$480,900 $60.0 p/Share	8,015 Reduced 100.0%	0 Common Stock
Dec 18 2020	BUY Exercise of conversion of derivative security	$4,809 $0.6 p/Share	8,015 Added 50.0%	8,015 Common Stock
Dec 17 2020	SELL Open market or private sale	$2,519,100 $60.0 p/Share	41,985 Reduced 100.0%	0 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$25,191 $0.6 p/Share	41,985 Added 50.0%	41,985 Common Stock
Dec 01 2020	SELL Open market or private sale	$289,845 $50.85 p/Share	5,700 Reduced 100.0%	0 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Nov 10 2020	SELL Open market or private sale	$2,250,000 $45.0 p/Share	50,000 Reduced 100.0%	0 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$70,000 $1.4 p/Share	50,000 Added 50.0%	50,000 Common Stock
Nov 02 2020	SELL Open market or private sale	$212,553 $37.29 p/Share	5,700 Reduced 100.0%	0 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Oct 01 2020	SELL Open market or private sale	$197,220 $34.6 p/Share	5,700 Reduced 100.0%	0 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock

HMN

Huw M. Nash

Chief Business Officer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account